Myoung-Hwa Lim

Title: Myoung-Hwa Lim: Innovator in Pharmacological Formulations

Introduction

Myoung-Hwa Lim is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmacology, particularly in the development of drug formulations that enhance patient compliance and therapeutic effectiveness.

Latest Patents

Lim holds a patent for a "Mosapride sustained-release formulation providing pharmacological and clinical effects with once-daily administration." This innovative formulation is designed for oral administration and consists of a double-layer structure. The fast-release layer allows for rapid drug release, while the sustained-release layer ensures prolonged pharmacological activity over 24 hours. The formulation utilizes a mixture of high-viscosity and low-viscosity hydroxypropyl methylcellulose (HPMC) to control the dissolution rate in varying pH environments within the gastrointestinal tract. Additionally, the small-sized preparation weighs 200 mg or less, which significantly improves drug compliance among patients.

Career Highlights

Myoung-Hwa Lim is currently associated with Korea United Pharm, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on creating formulations that not only meet clinical needs but also enhance the overall patient experience.

Collaborations

Lim has collaborated with esteemed colleagues, including Byung Jin Kim and Youn Woong Choi, to further advance research and development in pharmacological formulations.

Conclusion

Myoung-Hwa Lim's contributions to the field of pharmacology through his innovative formulations exemplify the importance of research and development in improving patient care. His work continues to influence the pharmaceutical industry positively.